Echo Therapeutics Inc (NASDAQ:ECTE)

2.45
Delayed Data
As of 3:08pm ET
 +0.11 / +4.70%
Today’s Change
0.39
Today|||52-Week Range
3.68
+81.48%
Year-to-Date
No recent news for Echo Therapeutics Inc.

Today’s Trading

Previous close2.34
Today’s open2.36
Day’s range2.36 - 2.49
Volume25,870
Average volume (3 months)102,421
Market cap$29.6M
Dividend yield--
Data as of 3:08pm ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)+24.84%
Earnings growth (this year)+59.66%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+439.17%
P/E ratioNM
Price/Sales951.08
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
--Sibannac Inc0.000.00%
NBYNovaBay Pharmaceutic...+0.07+12.48%
PPHMPPeregrine Pharmaceut...+0.21+0.90%
REPHRecro Pharma Inc-0.14-4.11%
Data as of 3:18pm ET, 03/02/2015

Financials

Next reporting dateMarch 26, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$27.6K
Annual profit (last year)-$19.1M
Net profit margin-69,084.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Scott Wayne Hollander
Vice President-Operations &
Product Development
Thomas H. Bishop
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account